Recently, we were thrilled to welcome Dr Alison Green to the Leadership Team as our Head of Laboratory Sciences! Read more about what she brings to Scottish Brain Sciences…
Professor Craig Ritchie has told an international Alzheimer’s conference that phase 3 clinical trial results for donanemab, the antibody drug designed to target and clear the amyloid plaques considered key to progression of Alzheimer’s disease, reveal the drug’s “profound” clinical effect.
With the publication of Scotland’s new dementia strategy, the government’s Chief Scientist for Health, Professor Anna Dominiczack says it is now an important time to help make life-changing discoveries – encouraging Scots to volunteer for research into progressive brain conditions.
Professor Craig Ritchie, CEO of Scottish Brain Sciences co-hosts the second international brain health summit in St Andrew’s, bringing together experts across the NHS, academia, and industry for a two-day conference.
With visits to both Boston, Massachusetts for the BIO Convention, as well as San Francisco, California, for an exciting Life Sciences reception, June 2023 was a big month for Scottish Brain Sciences. And one that also promised big things on the horizon!